KNSA Kiniksa Pharmaceuticals, Ltd. Total Asset Value of Company
Kiniksa Pharmaceuticals is advancing humanitarian developments while successfully ignoring political conflicts. The organization's asset volume demonstrates an upward trend, where the value of 848.07 captures this metric. The financial base relies on a flexible culture of innovation, although the severance of trade ties occasionally complicates the import of chemicals and the conduct of global research, which impacts the company's overall resource costs.
Analytical breakdowns and data insights for company Kiniksa Pharmaceuticals Ltd (KNSA)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Kiniksa Pharmaceuticals|KNSA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Kiniksa Corp|KNSA - Company Aggregate Debts|Debts to Book Capitalization Kiniksa Corp|KNSA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Kiniksa|Interim Coverage Ratio kiniksa.com
- net income and valuation multiples indicators:
Fundamental valuation:Kiniksa Pharmaceuticals
To identify the fundamental support for the Kiniksa Pharmaceuticals (KNSA) business, it is essential to evaluate the efficiency of its robotic laboratories and AI-driven biomarker analysis systems. The trend in the company's total assets, reverse-calculated via return on assets (ROA), reflects the aggregate value of all resources and liabilities, allowing investors to promptly track the actual scale of the asset base without waiting for quarterly reports.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets grifols.com GRFS|ADPT - Aggregate Company Assets|Aggregate Asset Value CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Aggregate Company Assets|Cumulative Company Assets BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|RIGL - Aggregate Company Assets|ANAB - Company Total Assets|ATXS: Company Total Assets|ENGN - Company Total Asset Base|Aggregate Company Assets RAPT Therapeutics|Total Business Assets JBIO (Aerovate)|Company Total Assets ACRS|Company Total Asset Base Kyverna Therapeutics, Inc|Aggregate Company Assets Tiziana Life Sciences TLSA|Company Total Assets cabalettabio.com CABA|VTYX - Aggregate Company Assets|Company Total Asset Base Theratechnologies, Inc. THTX|AVTX: Company Total Assets|Eledon Pharmaceuticals, Inc (ELDN) - Company Total Assets|Cumulative Company Assets AGEN|CLYM: Aggregate Asset Value|Aggregate Company Assets Zura Bio (ZURA)|ATYR: Total Asset Value of Company|Company Total Assets ADAG (Adagene Inc.)|Aggregate Asset Value IMA|Shattuck Therapeutics - Company Total Assets|EQ - Company Total Assets|connectbiopharm.com (CNTB) - Aggregate Company Assets|Immunic - Aggregate Asset Value|Aggregate Company Assets Atara Biotherapeutics, Inc.|Cumulative Company Assets InflaRx GmbH (IFRX)|Company Total Assets XFOR|Company Total Assets adicetbio.com (ACET)|Company Total Assets CELU (Celularity)|INMB - Cumulative Company Assets|Barinthus Bio - Company Total Assets|Company Assets Kezar Life Sciences Inc|SABS (SAB Biotherapeutics) - Cumulative Company Assets|akaritx.com (AKTX) - Company Total Assets|Cumulative Company Assets ENLV|QTTB (Q32 Bio Corp) - Aggregate Business Assets|Company Total Assets GOVX|Company Total Asset Base Edesa Biotech Corp|Company Total Assets IBIO (iBio, Inc.)|CARM - Cumulative Company Assets|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT - Company Total Assets|hcwbiologics.com (HCWB) - Aggregate Company Assets|APVO (Aptevo Therapeutics Inc.) - Aggregate Company Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aditxt Corp (ADTX) - Company Total Asset Base|Aggregate Company Assets GRI Bio (GRI)|Company Total Assets XORTX Therapeutics Inc (XRTX)|Aggregate Company Assets ReShape Lifesciences HIND|REVB: Total Business Assets|INDP - Aggregate Company Assets|Company Total Asset Base scinai.com SCNI|CALI: Company Total Assets|Affimed N.V. (AFMD) - Company Total Assets|Aggregate Company Assets Allakos Inc|HOOKIPA - Total Asset Value of Company|Company Total Assets IGMS|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD - Aggregate Company Assets